PCM, U., VT, S., & VF, A. (2014). Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists. Dove Medical Press.
Cita Chicago Style (17a ed.)PCM, Urbano, Soccol VT, y Azevedo VF. Apoptosis and the FLIP and NF-kappa B Proteins as Pharmacodynamic Criteria for Biosimilar TNF-alpha Antagonists. Dove Medical Press, 2014.
Cita MLA (8a ed.)PCM, Urbano, et al. Apoptosis and the FLIP and NF-kappa B Proteins as Pharmacodynamic Criteria for Biosimilar TNF-alpha Antagonists. Dove Medical Press, 2014.
Precaución: Estas citas no son 100% exactas.